Imax (IMAX) Cash & Equivalents (2010 - 2026)

Imax has disclosed Cash & Equivalents across 17 years of filings, most recently posting $159.9 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 46.31% year-over-year to $159.9 million; the TTM figure through Jun 2026 stood at $159.9 million (up 46.31% YoY), while the FY2025 annual figure was $151.2 million, up 50.28% from the prior year.
• Cash & Equivalents came in at $159.9 million for Q2 2026 at Imax, up from $146.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $162.3 million in Q1 2022 to a low of $76.2 million in Q4 2023.
• Average Cash & Equivalents over 5 years is $112.3 million, with a median of $102.5 million recorded in 2024.
• Year-over-year, Cash & Equivalents slumped 54.82% in 2022 and surged 50.4% in 2026.
• Over 5 years, Cash & Equivalents stood at $97.4 million in 2022, then retreated by 21.77% to $76.2 million in 2023, then surged by 32.01% to $100.6 million in 2024, then soared by 50.28% to $151.2 million in 2025, then gained by 5.79% to $159.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $159.9 million in Q2 2026, $146.0 million in Q1 2026, and $151.2 million in Q4 2025.